ELIZABETH WOOD: Open Payments
NPI 1376782763 · FEDERAL WAY, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,164 in 62 payments from 11 companies in 2025. Trend: 2023 $341 · 2024 $593 · 2025 $1,164
Food & beverage: $1,064Education: $100
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $271 |
| ABBVIE INC. | 9 | $207 |
| Novartis Pharmaceuticals Corporation | 22 | $174 |
| Lilly USA, LLC | 5 | $122 |
| Janssen Biotech, Inc. | 2 | $121 |
| Regeneron Healthcare Solutions, Inc. | 2 | $69 |
| Arcutis Biotherapeutics, Inc. | 3 | $56 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $55 |
| Galderma Laboratories, L.P. | 3 | $42 |
| Amgen Inc. | 1 | $27 |
Products named: DUPIXENT, SKYRIZI, COSENTYX, TALTZ, TREMFYA, Zoryve, Winlevi, AKLIEF.
Industry payments across WA — which companies pay providers there.
